OXYCODONE WKT oxycodone hydrochloride 10 mg/1 mL solution for injection or infusion glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wkt oxycodone hydrochloride 10 mg/1 ml solution for injection or infusion glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium citrate; sodium hydroxide; sodium chloride; hydrochloric acid; citric acid monohydrate - oxycodone wkt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE WOCKHARDT oxycodone hydrochloride 20 mg/2 mL solution for injection or infusion, glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wockhardt oxycodone hydrochloride 20 mg/2 ml solution for injection or infusion, glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium citrate; water for injections; citric acid monohydrate; sodium hydroxide - oxycodone wockhardt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE WOCKHARDT oxycodone hydrochloride 10 mg/1 mL solution for injection or infusion, glass ampoules Australia - English - Department of Health (Therapeutic Goods Administration)

oxycodone wockhardt oxycodone hydrochloride 10 mg/1 ml solution for injection or infusion, glass ampoules

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; citric acid monohydrate; water for injections; sodium chloride; sodium hydroxide; sodium citrate - oxycodone wockhardt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

HYDRALAZINE LINK hydralazine hydrochloride 20 mg/1 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

hydralazine link hydralazine hydrochloride 20 mg/1 ml solution for injection vial

link medical products pty ltd t/a link pharmaceuticals - hydralazine hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; propylene glycol - hypertensive crises, especially during late pregnancy (pre-eclampsia and eclampsia).

BACTHECAL baclofen 10 mg/5 mL intrathecal solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bacthecal baclofen 10 mg/5 ml intrathecal solution for injection ampoule

medsurge pharma pty ltd - baclofen, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

BACTHECAL baclofen 10 mg/20 mL intrathecal solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bacthecal baclofen 10 mg/20 ml intrathecal solution for injection ampoule

medsurge pharma pty ltd - baclofen, quantity: 10 mg - injection, solution - excipient ingredients: water for injections; sodium chloride - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

BACTHECAL baclofen 0.05 mg/1 mL intrathecal solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bacthecal baclofen 0.05 mg/1 ml intrathecal solution for injection ampoule

medsurge pharma pty ltd - baclofen, quantity: 0.05 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

OXYTOCIN APX oxytocin 10 IU/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

oxytocin apx oxytocin 10 iu/1 ml solution for injection ampoule

arrotex pharmaceuticals pty ltd - oxytocin, quantity: 10 iu/ml - injection, solution - excipient ingredients: acetic acid; chlorobutanol hemihydrate; water for injections - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

BUPIVACAINE-BAXTER bupivacaine hydrochloride (as monohydrate) 100 mg/20 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bupivacaine-baxter bupivacaine hydrochloride (as monohydrate) 100 mg/20 ml solution for injection vial

baxter healthcare pty ltd - bupivacaine hydrochloride, quantity: 5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 5.28 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections; sodium hydroxide - indications ,bupivacaine-claris is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: ,surgical anaesthesia ,epidural block for surgery ,field block (minor and major nerve blocks and infiltration). ,analgesia ,continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. ,field block (minor nerve block and infiltration).

BUPIVACAINE-BAXTER bupivacaine hydrochloride (as monohydrate) 50 mg/10 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bupivacaine-baxter bupivacaine hydrochloride (as monohydrate) 50 mg/10 ml solution for injection vial

baxter healthcare pty ltd - bupivacaine hydrochloride, quantity: 5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 5.28 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - indications ,bupivacaine-baxter is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: ,surgical anaesthesia ,epidural block for surgery ,field block (minor and major nerve blocks and infiltration). ,analgesia ,continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. ,field block (minor nerve block and infiltration).